FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1489073074> ?p ?o ?g. }

• W1489073074 endingPage "273" @default.
• W1489073074 startingPage "266" @default.
• W1489073074 abstract "The efficacy of long-term adefovir dipivoxil monotherapy or combination of adefovir and lamivudine in hepatitis B e antigen (HBe-Ag)-negative lamivudine-resistant chronic hepatitis B (CHB) patients is still under investigation.To assess the safety and efficacy of the long-term adefovir treatment alone or in combination with lamivudine in HBe-Ag-negative CHB patients who had developed breakthrough because of lamivudine-resistant mutants.Fifty-nine patients received combination therapy, while 23 switched to adefovir alone after a 3-month course of combination therapy.The median follow-up after adefovir's onset was 31 (18-40) months. Baseline characteristics were similar between the two groups. At 12 and 24 months, 69% and 89% of patients receiving combination therapy and 73% and 82% of patients receiving adefovir monotherapy had serum HBV-DNA <10(4) copies/mL (P > 0.5). Normalization of alanine aminotransferase levels occurred in 81% and 79% of patients receiving combination vs. 61% and 53% receiving adefovir monotherapy at 12 and 24 months, respectively (P > 0.50). Virological breakthroughs because of adefovir-resistant mutants occurred in five patients under adefovir monotherapy and in none receiving combination therapy (P = 0.001). No one developed decompensated liver disease or hepatocellular carcinoma during follow-up. Re-introduction of lamivudine in adefovir-resistant patients achieved reduction in HBV-DNA and biochemical remission, but re-emergence of lamivudine mutants was observed in one patient after 7.5 months.In HBe-Ag-negative CHB patients with lamivudine resistance, adding adefovir to continuing lamivudine therapy maximizes anti-viral efficacy because of absence of viral resistance." @default.
• W1489073074 created "2016-06-24" @default.
• W1489073074 creator A5008950143 @default.
• W1489073074 creator A5009708677 @default.
• W1489073074 creator A5010292222 @default.
• W1489073074 creator A5016318276 @default.
• W1489073074 creator A5019947956 @default.
• W1489073074 creator A5030128305 @default.
• W1489073074 creator A5039554874 @default.
• W1489073074 creator A5041736680 @default.
• W1489073074 creator A5051848552 @default.
• W1489073074 creator A5066417347 @default.
• W1489073074 creator A5086746443 @default.
• W1489073074 creator A5088143086 @default.
• W1489073074 creator A5089265147 @default.
• W1489073074 date "2007-11-06" @default.
• W1489073074 modified "2023-10-15" @default.
• W1489073074 title "Long-term therapy with adefovir dipivoxil in hepatitis B e antigen-negative patients developing resistance to lamivudine" @default.
• W1489073074 cites W1964242359 @default.
• W1489073074 cites W1981900811 @default.
• W1489073074 cites W1987843876 @default.
• W1489073074 cites W2006698257 @default.
• W1489073074 cites W2010318719 @default.
• W1489073074 cites W2013840689 @default.
• W1489073074 cites W2019144721 @default.
• W1489073074 cites W2041059721 @default.
• W1489073074 cites W2058376942 @default.
• W1489073074 cites W2065099361 @default.
• W1489073074 cites W2071074622 @default.
• W1489073074 cites W2080173085 @default.
• W1489073074 cites W2082603030 @default.
• W1489073074 cites W2088280741 @default.
• W1489073074 cites W2107704647 @default.
• W1489073074 cites W2119612879 @default.
• W1489073074 cites W2120667564 @default.
• W1489073074 cites W2133291642 @default.
• W1489073074 cites W2142557452 @default.
• W1489073074 cites W2149498593 @default.
• W1489073074 cites W2156015715 @default.
• W1489073074 cites W2169342982 @default.
• W1489073074 cites W4236152692 @default.
• W1489073074 doi "https://doi.org/10.1111/j.1365-2036.2007.03567.x" @default.
• W1489073074 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17988233" @default.
• W1489073074 hasPublicationYear "2007" @default.
• W1489073074 type Work @default.
• W1489073074 sameAs 1489073074 @default.
• W1489073074 citedByCount "45" @default.
• W1489073074 countsByYear W14890730742012 @default.
• W1489073074 countsByYear W14890730742013 @default.
• W1489073074 countsByYear W14890730742014 @default.
• W1489073074 countsByYear W14890730742015 @default.
• W1489073074 countsByYear W14890730742016 @default.
• W1489073074 countsByYear W14890730742018 @default.
• W1489073074 countsByYear W14890730742019 @default.
• W1489073074 countsByYear W14890730742021 @default.
• W1489073074 countsByYear W14890730742023 @default.
• W1489073074 crossrefType "journal-article" @default.
• W1489073074 hasAuthorship W1489073074A5008950143 @default.
• W1489073074 hasAuthorship W1489073074A5009708677 @default.
• W1489073074 hasAuthorship W1489073074A5010292222 @default.
• W1489073074 hasAuthorship W1489073074A5016318276 @default.
• W1489073074 hasAuthorship W1489073074A5019947956 @default.
• W1489073074 hasAuthorship W1489073074A5030128305 @default.
• W1489073074 hasAuthorship W1489073074A5039554874 @default.
• W1489073074 hasAuthorship W1489073074A5041736680 @default.
• W1489073074 hasAuthorship W1489073074A5051848552 @default.
• W1489073074 hasAuthorship W1489073074A5066417347 @default.
• W1489073074 hasAuthorship W1489073074A5086746443 @default.
• W1489073074 hasAuthorship W1489073074A5088143086 @default.
• W1489073074 hasAuthorship W1489073074A5089265147 @default.
• W1489073074 hasBestOaLocation W14890730741 @default.
• W1489073074 hasConcept C126322002 @default.
• W1489073074 hasConcept C159047783 @default.
• W1489073074 hasConcept C2522874641 @default.
• W1489073074 hasConcept C2776999253 @default.
• W1489073074 hasConcept C2777382497 @default.
• W1489073074 hasConcept C2777869810 @default.
• W1489073074 hasConcept C2779517838 @default.
• W1489073074 hasConcept C2780593183 @default.
• W1489073074 hasConcept C71924100 @default.
• W1489073074 hasConcept C90924648 @default.
• W1489073074 hasConceptScore W1489073074C126322002 @default.
• W1489073074 hasConceptScore W1489073074C159047783 @default.
• W1489073074 hasConceptScore W1489073074C2522874641 @default.
• W1489073074 hasConceptScore W1489073074C2776999253 @default.
• W1489073074 hasConceptScore W1489073074C2777382497 @default.
• W1489073074 hasConceptScore W1489073074C2777869810 @default.
• W1489073074 hasConceptScore W1489073074C2779517838 @default.
• W1489073074 hasConceptScore W1489073074C2780593183 @default.
• W1489073074 hasConceptScore W1489073074C71924100 @default.
• W1489073074 hasConceptScore W1489073074C90924648 @default.
• W1489073074 hasIssue "3" @default.
• W1489073074 hasLocation W14890730741 @default.
• W1489073074 hasLocation W14890730742 @default.
• W1489073074 hasOpenAccess W1489073074 @default.
• W1489073074 hasPrimaryLocation W14890730741 @default.
• W1489073074 hasRelatedWork W1983206060 @default.
• W1489073074 hasRelatedWork W2076187113 @default.

• next